Home
>
National Drug Code (NDC)
>
Methotrexate
Methotrexate - 51079-670-05 - (methotrexate)
Drug Information of Methotrexate
| Product NDC: | 51079-670 |
| Proprietary Name: | Methotrexate |
| Non Proprietary Name: | methotrexate |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; methotrexate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Methotrexate
| Product NDC: | 51079-670 |
| Labeler Name: | Mylan Institutional Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA081235 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130110 |
Package Information of Methotrexate
| Package NDC: | 51079-670-05 |
| Package Description: | 20 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-670-05) > 1 TABLET in 1 BLISTER PACK (51079-670-01) |
NDC Information of Methotrexate
| NDC Code | 51079-670-05 |
| Proprietary Name | Methotrexate |
| Package Description | 20 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-670-05) > 1 TABLET in 1 BLISTER PACK (51079-670-01) |
| Product NDC | 51079-670 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | methotrexate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130110 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | METHOTREXATE |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
